| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-08 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.2 | 6e-06 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.2 | 1e-05 |